alexa Flowcytometric Analysis of Cell Cycle in the Liver of Mice in vivo Exposed to (+)-α-Viniferin, a Phytostilbene | OMICS International
ISSN: 2161-1459
Journal of Clinical & Experimental Pharmacology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Flowcytometric Analysis of Cell Cycle in the Liver of Mice in vivo Exposed to (+)-α-Viniferin, a Phytostilbene

Roy B* and Pathaw D

Department of Zoology, North-Eastern Hill University, Shillong, India

*Corresponding Author:
Roy B
Department of Zoology
North-Eastern Hill University
Shillong, India
Tel: 00913642722331
E-mail: [email protected]

Received date: September 13, 2017; Accepted date: September 20, 2017; Published date: September 27, 2017

Citation: Roy B, Pathaw D (2017) Flowcytometric Analysis of Cell Cycle in the Liver of Mice in vivo Exposed to (+)-α-Viniferin, a Phytostilbene. Clin Exp Pharmacol 7:243. doi: 10.4172/2161-1459.1000243

Copyright: © 2017 Roy B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Experimental Pharmacology

Abstract

In vitro anticancer and anthelmintic properties of the phytostilbene (+)-α-viniferin had been established. However, contradictory reports are available about the mode of action of the chemical. Therefore, an in vivo investigation was carried out to see whether or not the cell cycle arrest is the cause of cell death in the albino mice exposed to (+)-α- viniferin. Cell cycle was analysed in the liver cells of albino mice treated with different concentrations of the phytochemical, through flow cytometer. The results showed a constant dose dependent (1 mg to 5 mg (+)-α- viniferin/kg body weight of mice) increase in number of cells in the SubG1 stage of cell cycle along with a steady decrease in the number of cells in G0/G1 phase. Thus no cell cycle arrest was evident in any phase of cell cycle in the mice exposed to different concentration of (+)-α-viniferin. The flow cytometric results were also supported by histochemical observations of large number of dead cells in the liver section of mice in vivo exposed to (+)-α- viniferin. An increase in cell death with an increase in the doses of the phytochemical as observed in the present study need to be study further to elucidate the mechanism of action of the compound leading the death of the liver cells in mice.

Keywords

Cell cycle; Albino mice; (+)-α-viniferin; Phytochemical

Introduction

Increased demand for phytomedicine in different parts of the globe is credited to the idea that "Green medicine" is not only easily available and cheap but also safe to consume [1]. However, review of literature revealed that the chemicals present in many traditionally used medicinal plants exert irreparable damage to liver, kidney, heart, brain, intestine and reproductive organs of its consumers [2-4]. (+)-α- viniferin (C42H30O9) is a polyphenolic phytoalaxin that naturally occurs in different traditionally used medicinal plants [5-11]. Thus a good quantity of the chemical is consumed regularly by economically weaker section of people in the developing country like India, through crude extract of different plants as folk medicine [12].

In Northeast India, different tribes consume 3 mg to 4 mg crude extract of Carex baccans (having 200 μM to 250 μM (+)-α- viniferin)/kg body weight/day continuously for 10 d to 15 d to cure intestinal helminth infection. It is reported that the phytochemical is toxic to cancerous cells and its toxicity is carried out through apoptotic cell death in several cancer cell lines [13]. However, Gonzalez-Sarrias et al. [10] observed that (+)-α-viniferin do not induce apoptosis in vitro, but arrest cell cycle in colon cancer cells. Therefore, because of its public health significance, an in vivo experiment was carried out involving (+)-α-viniferin to see whether or not the chemical induces cell cycle arrest leading to death of liver cells of albino mice.

Materials and Methods

Instruments and chemicals

Flow cytometer (FACSCalibur, Becton-Dickinson), gentleMACS Dissociator (Miltenyi Biotec, USA). Centrifuge, CELLQuest Pro software, fluorescence microscope (EVOS FL, Lifetechnologies), (+)-α- viniferin, propidium iodide solution (50 μg/ml propidium iodide with 0.2 mg/ml RNase) in phosphate buffer saline pH 7.4, chilled 70% ethanol, gentleMACS C tubes, MACS SmartStrainers (100 μm pore size), red blood cell lysis solution (10 X), Krebs-Ringer-Buffer (154 mM NaCl, 5.6 mM KCl, 5.5 mM glucose, 20.1 mM HEPES, 25 mM NaHCO3 pH 7.4), 0.5 M CaCl solution, 0.2 M MgCl solution, collagenase IV solution (containing 5000 collagenase digestion units/mL in KRB), DNase I solution (containing 30,000 U/mL DNase I in PEB buffer and 2 mM EDTA by diluting MACS BSA stock solution). PEB buffer (Phosphate buffered saline with 0.5% BSA and 2 mM EDTA; pH 7.2). DAPI (stock) solution (1 mg of 4’, 6’ diamino-2- phenylindole 2HCl in 1 ml distilled water), DAPI working solution (1 μl/ml was prepared from the DAPI stock solution in 1 X PBS), dimethyl sulfoxide (DMSO).

Animals and treatment

Experiment on animals was performed in accordance to the guidelines of OECD 407 [14] and Animal Ethics Committee’s guidelines for laboratory animal use and care, North-Eastern Hill University, Shillong, India. The mice were kept in metal cages in the animal house having uniform temperature of 25°C with 12 h light and 12 h dark periodicity. The animals were fed with standard feed and water ad libitum. All the mice were acclimatized for two weeks before starting the experiment. A total of 24 mice were separated in to four groups having six mice of either sex (3 males and 3 females) in each group. Different concentrations (1.0 mg, 2.0 mg and 5.0 mg) of (+)-α- viniferin per kg body weight of mice were administered orally once a day with the help of a gastric feeding tube. Control animals were fed up with PBS having 0.1% DMSO only. Administration of (+)-α-viniferin and vehicle (PBS having 1% DMSO) continued for 14 d, followed by starvation of mice for overnight. On day 15th, each mouse was anesthetized with chloroform and sacrificed for collection of liver.

For preparation of single cell suspension, the liver from control and (+)-α-viniferin treated mice were dissected out and single-cell suspension was prepared using gentleMACS Dissociators (as per manufacturer direction). Briefly, the liver was Krebs Ringer Buffer and transferred into C Tube containing pre-warmed (37°C) dissociation mix which contains 4.4 mL KRB, 20 μL CaCl2 solution, 50 μL MgCl2, 500 μL collagenase Type IV (500 CDU/mL) and 25 μL DNase I solution (150 U/mL). The C tube was closed tightly and attached upside down on the sleeve of the gentleMACS Dissociator. The gentleMACS Program m_liver_01 was run. After termination of the program, the C Tube was detached and incubated at 37°C for 30 min under slow continuous rotation. Again, the C Tube was attached onto the gentleMACS Dissociator and the program m_liver_02 was run. After termination of the program, the C tube was detached and a short centrifugation step was performed to collect the sample at the tube bottom (optional). The sample was resuspended and filtered into a 50 mL tube using MACS SmartStrainer (pore size 100 μm) pre wet with PEB buffer. The MACS SmartStrainer was washed with additional 10 mL PEB buffer. The MACS SmartStrainer was discarded and 10 mL of PEB buffer was added to the sample collected. The cell suspension was centrifuge at 17 xg to 21 xg for 4 min at 4°C to remove contaminating hepatocytes. The supernatant containing the target cells was collected and transfer to a new 50 mL tube rinsed with PEB buffer. The cell suspension was centrifuged again at 300 xg for 10 min at 4°C and the supernatant was discarded. The pellet was resuspended in 1 mL PEB buffer and 10 mL of RBC Lysis solution was added to it. After 5 min of incubation at room temperature, 30 mL of PEB buffer was added and centrifuged at 300 xg for 10 min at 4°C. The supernatant was discarded while the pellet was resuspended in 1 mL to 2 mL of PEB buffer and the final volume was made to 30 mL with PEB. Again the cell suspension was centrifuged at 300 xg for 10 min at 4°C. The supernatant was discarded while the pellet was resuspended with PEB buffer to the required volume for further applications.

Isolated cells were fixed with 70% ethanol, washed in PBS and resuspended in 500 μl of propidium iodide solution for 30 min at room temperature in dark. 10,000 cells were acquired for each sample and analysed with a FACSCalibur. The distribution of cells in the cell cycle was measured by CELLQuest Pro software.

For microscopic observations of dead cells, liver tissue of mice from control and (+)-α-viniferin treated mice were fixed in 4% paraformaldehyde and processed for sectioning. Liver sections (8 μm to 10 μm) were than washed in PBS 3 times for 5 min each and incubated with DAPI solution in dark for 10 min at room temperature. The sections were washed with PBS 3 times, mounted on a slide in 70% glycerol and viewed under a fluorescence microscope.

Results and Discussion

Figure 1 depict the flow cytometric cell count and its relative DNA content in the liver cells of control and (+)-α-viniferin (1 mg, 2 mg and 5 mg/kg body weight) treated mice. The population of cells in each phase was measured by a flow cytometer and was gated in histogram with M1 (G0/G1 phase), M2 (M phase), M3 (S phase) and M4 (sub- G1). The M4 gate indicates the sub-diploid DNA fraction and represents dead cells. The proportion of M4 increased gradually when the dose of (+)-α-viniferin increased from 1 mg to 5 mg/kg body weight. The percentage of cells in each phases of cell cycle is shown in Table 1. An increased in gated percentage in Sub G1 (M4) fraction from 9.89% at a dose of 1 mg/kg body weight to 21.7% at 2 mg/kg body weight and finally to 26.35% at 5 mg/kg body weight was observed when compared with that of the control (4%). This observation was accompanied by a gradual decreased in cell count from 83.49% at a dose of 1 mg/kg body weight to 73.48% at 2 mg/kg body weight and finally to 65.79% at 5 mg/kg body weight when compared to control which revealed to be 87.91% in G0/G1 (M1) phase (Table 1).

Stages Control (%) 1 mg/kg body weight (%) 2 mg/kg body weight (%) 5 mg/kg body weight (%)
G0/G1 87.91 83.49 73.48 65.79
S 6.66 5.91 4.69 6.69
G2/M 1.23 0.71 1.43 1.45
SubG1 4 9.89 21.7 26.35

Table 1: Gated percentage of liver cells of mice (in different phases of cell cycle) treated with (+)-α-viniferin at doses of 1 mg/kg body weight, 2 mg/kg body weight and 5 mg/kg body weight in comparison to control. SubG1 fractions represent dead cells.

clinical-experimental-pharmacology-cytometric-histogram

Figure 1: Flow cytometric histogram of control, 1 mg/kg, 2 mg/kg, and 5 mg/kg α-viniferin treated mice. X-axis denotes cell count, Yaxis denotes relative DNA content. 10,000 cells were acquired for each sample. M1 denotes G0/G1 population, M2 denotes S population, M3 denotes G2/M population and M4 denotes Sub G1 (dead cells) fraction.

DAPI stained liver cells of control mice showed large and uniformly stained nucleus, most of which are round in shape having intact nuclear membrane (Figure 2A). Mice treated with different concentrations of (+)-α-viniferin showed increased number of dead cells with increased doses and characterized by brightly stained condensed nuclei having disintegrated nuclear membrane (Figure 2B-2D).

clinical-experimental-pharmacology-stained-nucleus-liver

Figure 2: Micrographs showing DAPI stained nucleus of liver sections of control and (+)-α-viniferin treated mice. A: Control; B: Mice treated with 1 mg (+)-α-viniferin/kg body weight; C: Mice treated with 2 mg (+)-α-viniferin/kg body weight; D: Mice treated with 5 mg (+)-α-viniferin/kg body weight of mice. Sections of α- viniferin treated mice show presence of dead cells characterized by condensed chromatin which are brightly stained by DAPI, some of which also shows disintegrating nucleus (red arrow) when compared with control.

Cell division leading to formation of genetically identical daughter cells depends on four steps i.e. G1 (gap), S (synthesis), G2 and M (mitosis) phases of cell cycle. Between synthesis and multiplication phases, there are check points to check the status of DNA, so that the event of cycle can progress to the next phase. If any abnormality occurs in the genetic information, this has to be repaired first, and in such cases cell cycle arrest take place. In the event of irreparable damage, cell cycle arrest can lead to cell death [15]. Cellular response for cell cycle arrest is temporary and activated immediately following DNA damage by toxic substances, however, cell death response is a delayed process which correlates with the persistence to DNA damage resulting elimination of affected cell [16].

In the present study the percentage of SubG1 population of cells increased gradually as the concentration of (+)-α-viniferin increased, with the concomitant decrease in G0/G1 stage of cells. The flow cytometric results was also supported by the histochemical observation of an increased numbers of dead cells in DAPI stained liver cells of mice exposed to different concentration of (+)-α-viniferin. Though the number of dead cells increased with increased concentration of the phytochemical, no indication of cell cycle arrest at any stage of cell cycle was evident. In vitro study carried out on human colon cancer cells demonstrated that (+)-α-viniferin inhibit proliferation of colon cancer cells by inducing cell cycle arrest, but not apoptosis [10]. However, Chowdhury et al. [13] observed that the phytochemical is pro-apoptotic to several cancer cell lines as it causes caspase dependent apoptotic cell death.

DNA condensation and fragmentation as observed in the DAPI stained nucleus of liver cells of (+)-α-viniferin treated mice indicate probable involvement of caspase dependent mechanism of cell death. It is also established that nuclear translocation of apoptosis inducing factor in response to toxin's signals occurs in mammalian cells resulting nuclear condensation and DNA fragmentation [17]. Since DNA fragmentation can result from activation of caspase or the nuclear translocation of apoptosis inducing factor, it is prerequisite to carry out a thorough investigation to elucidate the exact mechanism of DNA damage leading to cell death in the mice treated with (+)-α- viniferin.

Conclusion

Based on the present observations, it may be concluded that (+)-α- viniferin is toxic to mice as different concentrations of the chemical cause cell death in liver. Further it is noted that death of liver cells in (+)-α-viniferin treated mice do not occur due to cell cycle arrest. Therefore, further in vivo investigation should be carried out to elucidate the mechanism of action of the phytochemical.

Acknowledgements

This study was supported by a research grant from the Department of Science and Technology, Govt. of India, New Delhi. Infrastructural facilities provided by the Department of Zoology and Department of Biotechnology and Bioinformatics, North-Eastern Hill University, Shillong, India are also acknowledged.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 5th Annual Congress on Chemistry in Drug Discovery & Designing
    April 16-17, 2018 Dubai, UAE
  • International Conference on Pharmaceutical Research and Development
    June 06-07, 2018 Baltimore, USA
  • 4th International Conference on Drug Discovery, Designing and Development
    June 27-28, 2018 Vancouver, Canada
  • 18th World Pharma Congress
    October 18-19, 2018 Warsaw, Poland

Article Usage

  • Total views: 84
  • [From(publication date):
    September-2017 - Dec 18, 2017]
  • Breakdown by view type
  • HTML page views : 62
  • PDF downloads : 22
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version